Amylyx Pharmaceuticals (NasdaqGS:AMLX) FY Conference November 10, 2025 04:30 PM ET Speaker2Okay, thanks, everybody. This is our last meeting of the day here at Guggenheim's second annual Healthcare Innovations Conference. I'm Seamus Fernandez, one of the biopharma analysts here at Guggenheim, and I'm really pleased to be joined by the co-CEOs of Amylyx. To my far right is Josh Cohen, and my immediate right is Justin Klee. Josh, Justin, thanks for joining us. Maybe just to orient people to the Amylyx story a ...